Skin Revolution

Following a double win at Cosmoprof 2026, UK demand for TDX20 is accelerating fast.

Thank you for taking a moment to read our recent update on Sisneo Bioscience’s extraordinary double triumph at Cosmoprof Worldwide Bologna 2026. It has been a defining moment for the TDX20 platform – and for the future of regenerative aesthetics. Cosmoprof 2026 has now closed its doors, and as the Sisneo Bioscience team returns to Spain, UK demand has surged.

Skin revolution. New skincare and anti-ageing system developed over ten years. The TDX-20 uses Sisneo’s ‘genosome’ technology to create ultra-concentrated serums directly in front of the client. Unlike traditional encapsulated products, which typically contain 3–4% active concentration, the TDX-20 enables up to 84% concentration, offering a new level of potency and personalisation.

Daydreams Skin/Body Therapy owner Sara Esler is part of a landmark moment in regenerative skincare following the unveiling of the TDX-20 device from Sisneo Bioscience to the UK spa and aesthetics industry during the inaugural Regenerative Summit. Daydreams is one of the first clinics chosen to be part of this breakthrough in skin treatments and retail products using genosomes. The response from clients has been wonderful. The first wave of treatment stock was soon exhausted.

TDX-20 is a new benchmark for regenerative treatments in the UK. With demand growing for non-invasive, results-led solutions, the device is anticipated to be adopted across leading spas and clinics over the coming year, with Daydreams proud to be at the start of the technology’s journey.